TB

This poster provides steps that the general public can take to prevent active TB disease.

This fact sheet discusses general information about latent TB infection (LTBI), TB transmission, and TB tests. The resource also provides information on LTBI testing, and treatment. 

This fact sheet discusses general information about latent TB infection (LTBI), TB transmission, and TB tests. The resource also provides information on LTBI testing, and treatment. 

This fact sheet discusses general information about latent TB infection (LTBI), TB transmission, and TB tests. The resource also provides information on LTBI testing, and treatment. 

This fact sheet provides information on signs and symptoms of multi-drug resistant TB (MDR TB), and action steps to be taken if a person (or someone they know) may have been exposed to TB. The material was developed to educate patients and community members at increased risk of MDR TB due to an outbreak in the East Metro-Minnesota region. 

This guide provides clinicians with an overview of drug-resistant tuberculosis. The guide includes tools that can be used by providers who participate in the management of patients with drug-resistant TB.

This fact sheet provides general information on distinguishing between TB and COVID-19 symptoms, as well as information on some risk factors for TB.

This fact sheet aims to provide clinicians with general information on the presence of nitrosamine impurities found in rifampin and rifapentine and its impact on the treatment for TB.

This poster aims to remind health professionals to continue to consider TB in patients presenting with symptoms and risk factors consistent with TB, regardless of their COVID-19 status.

This fact sheet provides information about active TB disease, latent TB infection, TB transmission, and signs and symptoms of TB disease. The resource also includes information on TB testing and treatment.